Daclatasvir dihydrochloride is a potent direct-acting antiviral agent primarily utilized in the treatment of Hepatitis C Virus (HCV) infection. Synthesized via multi-step organic chemistry involving specific heterocyclic coupling, it functions as an NS5A replication complex inhibitor. The compound features the molecular formula C28H26ClN7O2·2HCl and carries the CAS registry number 1290386-48-5.
Strictly contraindicated for patients with severe hepatic impairment unless combined with specific ribavirin protocols. Storage requires maintaining temperatures below 25°C in a dry, light-resistant environment to ensure chemical stability. Personnel handling the raw material must utilize appropriate PPE to prevent inhalation or dermal exposure risks.